Thromb Haemost 2022; 122(01): 048-056
DOI: 10.1055/a-1481-2733
Coagulation and Fibrinolysis

Acquired FXIII Deficiency is Associated with High Morbidity

Patricia Duque
1   Anesthesiology and Critical Care Department, Gregorio Marañon Hospital, Madrid, Spain
2   Gregorio Marañon Health Research Institute, Gregorio Marañon Hospital, Madrid, Spain
,
Maite Chasco-Ganuza
1   Anesthesiology and Critical Care Department, Gregorio Marañon Hospital, Madrid, Spain
,
Ariana Ortuzar
3   Department of Hematology, Gregorio Marañon Hospital, Madrid, Spain
,
Carolina Almaraz
1   Anesthesiology and Critical Care Department, Gregorio Marañon Hospital, Madrid, Spain
,
Estrella Terradillos
1   Anesthesiology and Critical Care Department, Gregorio Marañon Hospital, Madrid, Spain
,
Gloria Perez-Rus
3   Department of Hematology, Gregorio Marañon Hospital, Madrid, Spain
4   Internal Medicine Department, Complutense University, Madrid, Spain
,
3   Department of Hematology, Gregorio Marañon Hospital, Madrid, Spain
2   Gregorio Marañon Health Research Institute, Gregorio Marañon Hospital, Madrid, Spain
› Author Affiliations
Preview

Abstract

Background A factor XIII (FXIII) level >30% is considered necessary to prevent spontaneous bleeding. Bleeding is also a risk in patients with acquired FXIII deficiency, but the hemostatic level of FXIII in this context remains to be determined.

Methods We retrospectively analyzed all patients diagnosed with acquired FXIII deficiency at a large hospital over 3 years (study ID NCT04416594, http://www.clinicaltrials.gov) and assessed clinical data to identify the best cut-off point for FXIII activity to distinguish between low and high risk of major bleeding in a mixed medical and surgical population.

Results Of the 97 patients who experienced bleeding despite a normal coagulation test, 43.2% had FXIII activity <70%. FXIII activity was significantly lower in surgical patients and patients admitted to the intensive care unit (ICU). Low FXIII activity was significantly associated with long ICU stays and a high incidence of major bleeding.

Conclusion Acquired FXIII deficiency is associated with high morbidity. The hemostatic level of FXIII in the setting of acquired FXIII deficiency might be above 30%.

Author Contributions

P.D. contributed to the conception and design of this study, the collection and interpretation of data, the drafting of the manuscript, and the approval of the final version. M. C.-G. contributed to the conception and design of this study, the collection and interpretation of data, and the approval of the final version. A.O. contributed to the collection of data and the approval of the final version. C.A., E.T., and G.P.-R. contributed to the analysis and interpretation of data, the critical review of the article, and the approval of the final version. C. P. contributed to the conception and design of this study, the critical review of the article, and the approval of the final version.




Publication History

Received: 14 December 2020

Accepted: 09 April 2021

Accepted Manuscript online:
13 April 2021

Article published online:
06 June 2021

© 2021. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany